Life Science Sector Still In The Dark As UK-EU Trade Talks Make Progress
Industry Bemoans ‘Contradictory’ Guidance
Executive Summary
Hope is not lost as the EU sees a "narrow path" to a trade deal with the UK, but the life sciences industry is still facing uncertainty over key issues such as medicines batch testing.
You may also be interested in...
‘Public Health Crisis’ Warning For Northern Ireland Over Post-Brexit Guidance
With the likelihood of a UK-EU trade deal still in the balance, the UK life sciences industry has called for clarification from UK and EU regulators regarding the regulatory situation in Northern Ireland from next year.
‘Public Health Crisis’ Warning For Northern Ireland Over Post-Brexit Guidance
With the likelihood of a UK-EU trade deal still in the balance, the UK life sciences industry has called for clarification from UK and EU regulators regarding the regulatory situation in Northern Ireland from next year.
Brexit: Companies Must ‘Act Now’ To Avoid Drug Supply Disruptions In 2021
In its latest letter to medicines and medical product companies, the UK's Department of Health and Social Care says the biggest potential cause of disruption to supplies could be failure to prepare for border controls implemented by the EU member states after the end of the Brexit transition period.